China being the world’s second largest healthcare market, manufactures a wide variety of medical products as well as medically related items to exacting specifications. The China Medical Supplies Market, analyzed by Astute Analytica was valued at US$ 53,963.2 Mn in 2021 and is estimated to reach US$ 73,228.7 Mn by 2027. The market is registering a CAGR of 5.2% over the projection period 2022-2027. Currently, Chinese factories produce medical items like gloves and gowns, as well as specialized medical products like imaging, anesthesia, and dialysis equipment. Further, sophisticated medical equipment is manufactured on a regular basis in China, and then exported to clients across the globe. Moreover, as part of China’s “Made in China 2025” initiative, China’s high-tech factories are working hard to bring their manufacturing in the most technical areas of medical equipment up to world-class standards. Manufacturing facilities in China are strenuously regulated and are accommodating to their foreign clients.
The market is majorly driven by factors such as growing healthcare expenditure coupled with rising geriatric population and effective measures of government to ensure crucial medical supplies to Hebei province amidst the new coronavirus outbreak. China has one of the fastest growing ageing populations in the world. According to World Health Organization (WHO), the population of people over 60 years old in China is projected to reach 28% by 2040, due to longer life expectancy and declining fertility rates. By 2019, there were 254 million older people aged 60 and over, and 176 million older people aged 65 and over. And by 2040, an estimated 402 million people (28% of the total population) will be over the age of 60. Further, rising healthcare expenditure coupled with growing geriatric population is propelling the market growth. Further, China has been exploring innovative approaches to improving access to integrated care, including the establishment of an internet-based medical information platform. Continued investment in these innovations and creating an integrated, community-based social and health care system, along with chronic disease control and prevention, are expected to drive the market growth over the forecast period. Moreover, the Chinese government’s effective measure to ensure crucial medical supplies to Hebei Province amid COVId-19 and government adaptability to take measures immediately as per the seriousness of disease is further accelerating the market growth. In addition, growing demand for smart medical supplies in the healthcare industry is providing a lucrative opportunity for market growth over the forecast period. However, the volatile regulatory system in China may hinder market growth.
The covid-19 pandemic has led to a growth in revenue of the China medical supplies market. The novel coronavirus disease has revealed many countries overdependence on China for active pharmaceutical ingredients (API) and other medical supplies. Further, many dominant players are now emerging, and new innovative products are high in demand, which is further propelling the market growth.
The key players in the China Medical Supplies Market are Sichuan Nigale Biomedical Co., Ltd., Jiangsu Likang Group Corporation, Shandong Qiaopai Group, Shanghai Johnson & Johnson Co. Ltd., and Suzhou Capsugel Co. Ltd., among others. Through extensive research, it is found that big players have adopted various competitive strategies such as merger & acquisition in order to have a grip in the stabilized China market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.
The following are the various segments of the China Medical Supplies Market:
By Applicationsegment of the China Medical Supplies Market is sub-segmented into:
By End Usersegment of the China Medical Supplies Market is sub-segmented into:
China Medical Supplies Market was valued at US$ 53,963.2 Mn in 2021.
China is the world’s second largest healthcare market and manufactures a wide variety of medical products as well as medically related items to exacting specifications.
As part of China’s “Made in China 2025” initiative, China’s high-tech factories are working hard to bring their manufacturing in the most technical areas of medical equipment up to world-class standards.
China Medical Supplies Market is estimated to expand at a CAGR of 5.2% over the forecast period.
The market is majorly driven by factors such as growing healthcare expenditure coupled with rising geriatric population and effective measures of government to ensure crucial medical supplies to Hebei province amidst the new coronavirus outbreak.
The volatile regulatory system in China may hinder market growth.
Growing demand for smart medical supplies in the healthcare industry is providing a lucrative opportunity for market growth over the forecast period.
Catheters dominates the market in 2021.
Cardiology segment is the highest application segment in the medical supplies market of China in 2021.
Hospitals are the highest end users in the market in 2021.
The key players in the China Medical Supplies Market are Sichuan Nigale Biomedical Co., Ltd., Jiangsu Likang Group Corporation, Shanghai Johnson & Johnson Co. Ltd., and Suzhou Capsugel Co. Ltd., among others.
COVID-19 had a positive impact on the medical supplies market of China.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.
SPEAK TO AN ANALYST